SciMed Medical AI Governance

MEDICAL AI GOVERNANCE

Regulatory Confidence for MedTech Manufacturers in the Age of AI

1,000+

Regulatory submissions across the UK and EU

over 20

Notified Bodies & Approved Bodies Reviewed SciMed-supported documentation

11+ years

Supporting MedTech & IVD Clients Across the Full Device Lifecycle

Artificial intelligence is transforming the MedTech industry. It is becoming increasingly embedded within medical devices and IVDs, while simultaneously reshaping how regulatory and quality teams develop documentation, evaluate evidence, manage compliance, and support decision-making.

These developments undoubtedly create significant opportunities for innovation, efficiency, and improved patient outcomes, but they also introduce new regulatory, operational, and governance challenges. Manufacturers must now navigate evolving AI regulations, establish appropriate governance frameworks, maintain regulatory compliance, and ensure AI-related activities remain explainable, reviewable, and defensible.

SciMed helps MedTech manufacturers achieve Regulatory Confidence when developing, deploying, or using artificial intelligence, whether AI sits inside your product, your regulatory operations, or both, our Medical AI Governance services help organisations adopt AI responsibly while maintaining compliance, accountability, and scientific integrity.

Why Medical AI Governance Matters

AI is no longer a future consideration for MedTech manufacturers; it is already influencing how products are developed, how evidence is generated, and how regulatory and quality activities are performed.

But for many organisations, AI introduces a new layer of complexity that sits across existing regulatory and quality frameworks in two broad ways:

1) Manufacturers developing AI-enabled products…

…must now consider:

  • AI Act Applicability,

  • Classification and Conformity Assessment Implications,

  • Training and Validation Data Governance,

  • Technical Documentation Requirements,

  • AI Lifecycle Management, and

  • Post-Market Monitoring Obligations.

At the same time…

2) Regulatory and quality teams are increasingly exploring AI to support their day-to-day activities:

  • Literature reviews

  • PMCF activities

  • Technical documentation development

  • SOP authoring and maintenance

  • Complaint investigations

  • Quality management activities

Without appropriate governance, both scenarios can create unnecessary risk, duplicated effort, weak evidence packages, and future remediation work.

The organisations most likely to succeed are not necessarily those adopting AI fastest, they are the organisations adopting AI in ways that remain controlled, transparent, and regulatorily defensible.

The Two Medical AI Challenges Facing Manufacturers

Although Medical AI is often discussed as a single topic, manufacturers typically face one of two distinct challenges.

Understanding which challenge applies to your organisation is the first step towards establishing an effective governance strategy.

MedTech Products; AI Regulations

For manufacturers developing AI-enabled medical devices and IVDs

The introduction of AI can significantly affect regulatory strategy, technical documentation requirements, lifecycle controls, and post-market obligations.

The Outcome:

Innovation Without Regulatory Debt

SciMed helps manufacturers build regulatory strategy, governance, and evidence generation into AI-enabled products from the beginning, reducing the risk of costly remediation and future compliance burdens.

Common challenges include:

  • Determining whether AI-specific regulations apply,

  • Understanding AI Act obligations,

  • Integrating AI requirements with MDR and IVDR compliance activities,

  • Governing training, validation, and testing datasets,

  • Managing model updates and lifecycle controls, or

  • Establishing AI-specific post-market monitoring activities.

AI-Enabled Regulatory Operations

For regulatory and quality teams adopting AI

Many organisations are already using AI to support documentation development, literature reviews, quality activities, and operational workflows. The key issue to come to terms with is ensuring those activities remain accountable, transparent, and defensible.

The Outcome:

Audit-Defensible AI Operations

SciMed helps regulatory and quality teams adopt AI in ways that improve efficiency while maintaining compliance, oversight, and scientific integrity.

Common challenges include:

  • Governing AI-assisted CER development,

  • Managing AI-supported literature reviews,

  • Establishing AI output validation processes,

  • Integrating AI controls into ISO 13485 quality systems,

  • Defining accountability and review responsibilities, or

  • Demonstrating audit-ready governance.

The SciMed Medical AI Governance Framework

Achieving Regulatory Confidence requires more than understanding AI regulations, it requires a structured approach to governance, evidence generation, oversight, and lifecycle management.

The SciMed Medical AI Governance Framework provides a practical methodology for helping manufacturers establish and maintain confidence in AI-related activities and consists of five interconnected pillars:

Govern pillar of the SciMed Medical AI Governance Framework illustrating governance, accountability and organisational oversight for AI-enabled medical device compliance.

Govern

Establish ownership, accountability, decision-making authority, and governance controls.

Outcome: Clear accountability and oversight.

Assess

Understand intended use, risks, obligations, and compliance implications.

Outcome: Clarity on priorities, risks, and regulatory expectations.

Validate pillar of the SciMed Medical AI Governance Framework illustrating validation of AI systems, evidence generation and demonstration that AI outputs are reliable and fit for purpose.

Validate

Demonstrate that AI systems and AI-supported outputs are reliable, appropriate, and fit for purpose.

Outcome: Confidence that outputs can be trusted and defended.

Control

Embed AI within existing regulatory and quality systems.

Outcome: Controlled, repeatable, and compliant processes.

Monitor pillar of the SciMed Medical AI Governance Framework illustrating ongoing lifecycle monitoring of AI systems, regulatory changes, performance and compliance.
Assess pillar of the SciMed Medical AI Governance Framework illustrating assessment of AI intended use, regulatory obligations, risks and compliance requirements.
ernance Framework illustrating assessment of AI intended use, regulatory obligations, risks and compliance requirements.

Monitor

Maintain oversight throughout the lifecycle of AI systems and AI-supported activities.

Outcome: Ongoing confidence as technologies, regulations, and risks evolve.

How We Help

Our Medical AI Governance services are built around two gateway assessments designed to help manufacturers understand their current position and establish a practical path forward.

AI Compliance Assessment

For organisations developing AI-enabled products.

The AI Compliance Assessment evaluates:

  • Applicability of AI-specific regulations

  • Regulatory obligations

  • Compliance gaps

  • Documentation readiness

  • Governance maturity

Deliverables include:

  • Compliance assessment report

  • Obligations matrix

  • Prioritised roadmap

AI Governance Diagnostic

For organisations using AI within quality & regulatory operations

The AI Governance Diagnostic evaluates:

  • Current AI use cases

  • Governance maturity

  • Validation approaches

  • Oversight mechanisms

  • Audit readiness

Deliverables include:

  • Governance diagnostic report

  • AI use register

  • Governance roadmap

  • Executive briefing

Why SciMed

Medical AI sits at the intersection of emerging technology, regulatory compliance, clinical evidence, and quality management, and because of this, effective governance requires more than generic AI advice.

It requires an understanding of how regulatory expectations translate into documentation, procedures, evidence, and day-to-day operational practice.

SciMed combines deep MedTech regulatory expertise with practical implementation experience to help manufacturers navigate this evolving landscape using an approach guided by four principles:

  • Scientific Authority

    • Evidence-based guidance grounded in MedTech regulatory and scientific practice.

  • Flawless Execution

    • Documentation, governance frameworks, and evidence systems built for scrutiny.

  • Long-Term Partnership

    • Support extending beyond individual projects to sustained compliance and governance maturity.

  • Innovation with Integrity

    • Practical AI adoption that improves performance without compromising regulatory control.

Medical AI Insights & Resources

A practical guide to understanding how emerging AI obligations interact with existing MedTech regulations.

Explore practical guidance on Medical AI Governance, AI-enabled products, and AI-enabled regulatory operations.

What you manufacturers of AI-enabled medical devices should understand about the EU AI Act

Bring Medical AI Under Control

Whether your organisation is developing AI-enabled products or introducing AI into regulatory and quality operations, the first step is understanding your current position. SciMed helps MedTech manufacturers achieve Regulatory Confidence through structured governance, practical compliance support, and evidence-based implementation.

Discuss Your Medical AI Challenge With a Senior Consultant